epidarex.com
Epidarex | New Drug Discovery Company Announces Additional Funding to Tackle Chronic Respiratory Disease
http://www.epidarex.com/new-drug-discovery-company-announces-additional-funding-to-tackle-chronic-respiratory-disease
New Drug Discovery Company Announces Additional Funding to Tackle Chronic Respiratory Disease. By Matthew Miessau In All. Brighton, Sussex, May 20th 2015 – Enterprise Therapeutics Ltd. Martin Gosling, CSO of Enterprise Therapeutics commented, We are extremely excited to have secured additional funding from experienced and enabling partners who will help us to shape and grow our company . Rob Woodman, Director Healthcare Ventures at Imperial Innovations commented Respiratory disease remains an area of hig...
epidarex.com
Epidarex | Portfolio
http://www.epidarex.com/portfolio
Backing highly innovative entrepreneurs developing disruptive technologies. Apellis is developing therapeutics for the treatment of several major diseases, including the protection of red blood cells against immune destruction. Edinburgh, United Kingdom. Caldan, a spin-out company from the Universities of Glasgow and Southern Denmark, is developing novel therapeutics targeting free fatty acid receptors for Type 2 Diabetes (T2D) and other potential indications. Glasgow, United Kingdom. St Louis, MO. Enter...